Completed PHASE1 INTERVENTIONAL 3-arm NCT00762151

A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste

Clinical Research Study to Investigate the Anti-Plaque Effect of a Prototype Toothpaste Containing an Anacor Material Via the MGMPI Method

Sponsor: Pfizer

Conditions Dental Plaque

Interventions Negative Control (Regular Toothpaste) Positive Control (anti-plaque/anti-bacterial toothpaste) Prototype (AN0128 Toothpaste)

Updated 7 times since 2017 Last updated: Jun 3, 2019 Started: Nov 30, 2007 Primary completion: Jan 31, 2008 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Dental Plaque, this trial is completed. The trial is conducted by Pfizer and has accumulated 7 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jul 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Jul 2019 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer

Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cedar Knolls, United States